Healio18h
FMT safe, linked to reduced hepatic encephalopathy recurrence in patients with cirrhosis
Fecal microbiota transplant, regardless of dose or route, was safe and associated with reduced hepatic encephalopathy ...
Rolling Out1d
4 critical liver warning signs your liver is in trouble
In the grand theater of human health, the liver plays a starring role, yet it rarely gets the spotlight it deserves. This ...
A Promising Development for Millions of People With Liver Disease
Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.
Frontiers19h
Molecular Insights into Fatty Liver Disease: Pathogenesis, Progression, and Therapeutic Strategies
Fatty liver disease, encompassing metabolic-associated fatty liver disease (MAFLD) and alcohol-associated liver disease (ALD), is now a significant global ...
Disappearance of Decompensated Liver Cirrhosis Episodes After Treatment with Can-Fite's Namodenoson
Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030Ramat Gan, Israel, Feb. 18, 2025 (GLOBE ...
Can-Fite reports disappearance of decompensated liver cirrhosis episodes
Can-Fite BioPharma (CANF) announced a significant clinical development: the disappearance of episodes of decompensated liver cirrhosis ...